PROPHYLACTIC TUBERCULOSIS VACCINE

The invention relates to the use of an immunotherapeutic agent containing cell wall fragments of a virulent strain of Mycobacterium tuberculosis- complex (MTB-C) for the preparation of a drug for the prophylactic treatment of tuberculosis, in which said agent can be obtained using a method comprisin...

Full description

Saved in:
Bibliographic Details
Main Authors ISABEL AMAT RIERA, PERE JOAN CARDONA IGLESIAS
Format Patent
LanguageEnglish
Published 03.09.2010
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention relates to the use of an immunotherapeutic agent containing cell wall fragments of a virulent strain of Mycobacterium tuberculosis- complex (MTB-C) for the preparation of a drug for the prophylactic treatment of tuberculosis, in which said agent can be obtained using a method comprising the following steps: cultivate the virulent MTB-C strain over a period equal to or greater than three weeks; and, subsequently, homogenate the cell culture in the presence of a nonionic surfactant.
AbstractList The invention relates to the use of an immunotherapeutic agent containing cell wall fragments of a virulent strain of Mycobacterium tuberculosis- complex (MTB-C) for the preparation of a drug for the prophylactic treatment of tuberculosis, in which said agent can be obtained using a method comprising the following steps: cultivate the virulent MTB-C strain over a period equal to or greater than three weeks; and, subsequently, homogenate the cell culture in the presence of a nonionic surfactant.
Author PERE JOAN CARDONA IGLESIAS
ISABEL AMAT RIERA
Author_xml – fullname: ISABEL AMAT RIERA
– fullname: PERE JOAN CARDONA IGLESIAS
BookMark eNrjYmDJy89L5WRQDAjyD_CI9HF0DvF0VggJdXINcg718Q_2DFYIc3R29vRz5WFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8R7ehobGFuYWZo6GxkQoAQDSHiPd
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID HK1138786A1
GroupedDBID EVB
ID FETCH-epo_espacenet_HK1138786A13
IEDL.DBID EVB
IngestDate Fri Jul 19 12:46:44 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_HK1138786A13
Notes Application Number: HK20100105629
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100903&DB=EPODOC&CC=HK&NR=1138786A1
ParticipantIDs epo_espacenet_HK1138786A1
PublicationCentury 2000
PublicationDate 20100903
PublicationDateYYYYMMDD 2010-09-03
PublicationDate_xml – month: 09
  year: 2010
  text: 20100903
  day: 03
PublicationDecade 2010
PublicationYear 2010
RelatedCompanies ARCHIVEL FARMA S.L
RelatedCompanies_xml – name: ARCHIVEL FARMA S.L
Score 2.7812536
Snippet The invention relates to the use of an immunotherapeutic agent containing cell wall fragments of a virulent strain of Mycobacterium tuberculosis- complex...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title PROPHYLACTIC TUBERCULOSIS VACCINE
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100903&DB=EPODOC&locale=&CC=HK&NR=1138786A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT4NAEJ401ag3rRrrK5gYbkQouMCBmLJAqK1AKDT11CyPTXqpjcX49x2QVi96m-wms49kZvab1wLcE85UvSi4ZAx0LmlawZDiuWSqhanlAzlnrMm2CIifas_zx3kHlttamKZP6GfTHBElKkd5rxp9vf5xYjlNbuXmIVvi0NuTl1iO2KJjRa7dDqJjW24UOiEVKbX8sRjElqKohm6QIQKlPXxF67UwuDO7LkpZ_7Yo3jHsR8hsVZ1Ap1z14JBuP17rwcFLG-9GshW9zSncRXEY-a-TOuuDCklquzFNJ-F0NBVmQ0pHgXsGgucm1JdwrcXuXAt_vNuVeg5dhPvlBQhE4wohOi8RbGhGSZiJGihTc4OxgZFzpQ_9P9lc_jN3BUffkW9TktVr6FbvH-UNGtQqu22u4gsXHXd_
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT4NAEJ401VhvWjXWJyaGG7EUusCBmHahoZYCodDUU7M8NumlNhbj33dAWr3obbKbzD6SmdlvXgvwSDhTtCzjkt7TuKSqGUOKp5KhZIaa9ropY1W2hUecWH1Z9BcNWO1qYao-oZ9Vc0SUqBTlvaj09ebHiWVVuZXbp2SFQ2_Po8i0xBody93S7SBaQ9MOfMunIqWmMxG90JRlRdd0MkCgdIAvbK0UBns-LItSNr8tyugEDgNkti5OoZGv29Ciu4_X2nA0rePdSNaitz2DhyD0A-fVLbM-qBDFQzuksevPxjNhPqB07NnnIIzsiDoSrrXcn2vpTPa7Ui6giXA_vwSBqFwmROM5gg1VzwkzUAMlSqoz1tNTLneg8yebq3_m7qHlRFN36Y69yTUcf0fBDamr3ECzeP_Ib9G4FslddS1f3Fl6cg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PROPHYLACTIC+TUBERCULOSIS+VACCINE&rft.inventor=ISABEL+AMAT+RIERA&rft.inventor=PERE+JOAN+CARDONA+IGLESIAS&rft.date=2010-09-03&rft.externalDBID=A1&rft.externalDocID=HK1138786A1